Toxicology Faciliites
Chengdu, Sichuan, China

Corporate Headquarters
20251 Century Blvd.
Suite 325
Germantown, MD 20874
U.S.A.

Phone: (301) 515-5560
Fax: (301) 515-5562

Discovery – PK/TK

In Vivo PK/PD, TK Analysis, ADME

Frontier’s scientific staff has the experience and expertise to design, conduct, and interpret non-GLP in vivo PK/ADME studies utilizing standard specie types, and can help achieve your study goals with quick study initiation and expedited reporting timelines. We are also able to provide a variety of analytical and bioanalytical services for blood, plasma, serum, CSF, or tissue and organs.

Why place your PK screening studies at Frontier?

  • Study Directors with >20 years experience conducting PK studies
  • Studies typically start within 2 weeks from contract execution (no waiting time for non-human primates)
  • Full-time in-house and experienced pharmacokineticists
  • Guaranteed supply of non-human primates
  • Validated WinNonlin® analysis software
  • Studies conducted in the spirit of GLP

Research Models

  • Metabolic – Hepatic Fibrosis, Type II Diabetes
  • Oncology
  • Immunology – Vaccines
  • Cardiovascular
  • Ophthalmology – Laser-induced choroidal neovascularization in Rhesus monkeys and rabbits
  • Radiation protection in non-human primates and rodents